Position
Parallel Advisors, LLC in Immunovant, Inc.
Back to the book · All holders of IMVT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$62$25.42 → $24.84
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 108 | $2.75K | — | — | — | 0.0% |
| Q1 2026 | 108 | $2.68K | $24.84 | −$62 | $0 | 0.0% |